CHEMOPREVENTION OF MALIGNANCIES, THE STAN DPOINT OF SOCIAL-SECURITY

Faced with scientific progress, social security must be concerned by e thics, especially by protection of personal integrity. Financial neces sities lead to fake into account the efficiency of public health inter ventions. But in front of potentially toxic drug, are we allowed to co mpare possible advantages with potentially serious risk for healthy wo men? For these reasons, social security takes a stand in favour of car efully controlled trials, focused on restricted target populations whi ch are estimated at high risk of cancer. Research of side effects shou ld be included in the follow of the patients and special caution shoul d be taken to avoid premature spreading of this behaviour About a fina ncial contribution of social security, the National fund for health pr evention education and information (FNPEIS) could perhaps not support such a project. regarding to his experimental nature. CNAMTS-INSERM re search contracts could be an alternative.